Pereskia grandifolia
Pereskia grandifolia · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Pereskia grandifolia is a unique botanical species that has garnered significant scientific interest due to its potential medicinal properties. Research indicates that the ethanol-soluble fraction of its leaves, prepared in powder form, exhibits notable hepatoprotective activities. These therapeutic effects are particularly relevant in defending the liver against damage caused by cigarette smoking and hypoxia. Furthermore, the plant demonstrates a capacity to mitigate the harmful impacts of oxidative stress within biological systems. Consequently, studying this species offers promising avenues for developing natural interventions to support hepatic health.
- Synonyms
- Pereskia Tampicana · Rhodocactus Tampicanus · 4 more
- Common names
- Not available
- Family
- Cactaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Pereskia grandifolia is a unique botanical specimen known by several diverse common names depending on the region. It is frequently referred to as the Cacto rosa brasileño or simply the Cactus rosa in various contexts. In other areas, local inhabitants may call the plant Figueira-espinhenta or Gameleira-de-espinho. Additionally, it is sometimes identified by the name Guamacho morado. These various aliases highlight the widespread recognition of this fascinating species across different cultures.
Sources: Catalogue of Life (COL)
Synonyms
Pereskia grandifolia is a botanical subject known for its complex taxonomic history and numerous scientific aliases. Throughout various studies, this species has been identified by several different synonyms, including Cactus rosa and Pereskia ochnacarpa. Researchers have also utilized names such as Pereskia rosea and Pereskia tampicana when classifying this particular plant. Furthermore, it is sometimes referred to in literature as Rhodocactus grandifolius. Understanding these shifting botanical relationships is essential for accurate identification and scientific consistency.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Pereskia grandifolia belongs to the kingdom Plantae, representing a unique branch of the botanical world. Within this vast kingdom, the species is classified under the class Equisetopsida. It further resides in the order Caryophyllales, showcasing its evolutionary connections to other diverse plant groups. As a member of the family Cactaceae, it shares structural traits with many well-known succulents. Ultimately, this plant is defined by its specific placement within the genus Pereskia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Caryophyllales |
| Family | Cactaceae |
| Genus | Pereskia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Pereskia grandifolia exhibits a widespread distribution that spans across several key regions in the Eastern Hemisphere. In Africa, this species can be found throughout the Western Indian Ocean, specifically inhabiting areas like Mauritius and Réunion. Its reach extends significantly into Asia-Tropical territories, where it thrives within the Indian Subcontinent. Detailed records show its presence in specific locales such as Assam and Bangladesh. Ultimately, the plant maintains a robust foothold across India, highlighting its adaptability to diverse tropical environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Pereskia grandifolia has demonstrated significant hepatoprotective activity, offering a promising avenue for treating metabolic-associated fatty liver disease (MAFLD). Recent research utilizing a diabetic rat model shows that the plant's ethanol-soluble fraction can effectively mitigate hepatic damage caused by high-fat diets and cigarette smoke. By reducing elevated levels of AST and ALT, the extract helps restore liver function and improves disrupted lipid profiles. Furthermore, the plant exhibits essential anti-inflammatory properties by inhibiting macrophage spreading and phagocytosis. These findings suggest that P. grandifolia is a safe and potent therapeutic candidate for protecting the liver against metabolic disturbances.
Compounds
Conditions
Pereskia grandifolia demonstrates significant therapeutic potential in the treatment of Metabolic-Associated Fatty Liver Disease (MAFLD). The plant extract effectively mitigates the hepatic damage and metabolic disturbances caused by risk factors such as cigarette smoking. Research indicates that it provides notable anti-inflammatory effects by inhibiting macrophage spreading and phagocytosis. Furthermore, the administration of the plant helps to reverse elevated levels of ALT, which is a key marker of liver injury. These combined properties highlight its promise as a hepatoprotective agent against various metabolic complications.
Preparations
Pereskia grandifolia is prepared as an ethanol-soluble fraction to assess its safety and efficacy in treating metabolic-associated fatty liver disease. This specific fraction was utilized in studies to examine its hepatoprotective, anti-inflammatory, and toxicity-related properties. Additionally, Pereskia grandifolia is prepared as a powder form through a process of drying and blending leaves. This powdered material is subsequently extracted in methanol to produce crude extracts for cytotoxicity testing. These two distinct preparation methods allow researchers to investigate the plant's therapeutic potential across various biological models.
Parts used
Pereskia grandifolia possesses leaves that were utilized as the primary source for producing methanol extracts in this study. These botanical extracts were processed into a powder form to examine their cytotoxic potential against human Saos-2 osteosarcoma cells. Researchers specifically compared the efficacy of these leaf extracts under both normoxic and hypoxic microenvironmental conditions. The results indicated that hypoxia significantly increased the IC50 values for the Pereskia grandifolia extract, suggesting a change in its potency. Ultimately, the study highlights how oxygen levels can variably alter the biological effects of plant-derived treatments on cancer cells.